Pharma major Lupin Limited announced the launch of the United States Food and Drug Administration (FDA) approved atorvastatin calcium tablets USP, 10 mg, 20 mg, 40 mg, and 80 mg.The product will be manufactured at Lupin's Nagpur facility in India.Atorvastatin calcium tablets USP, 10 mg, 20 mg, 40 mg, and 80 mg, is the generic equivalent of Lipitor tablets, 10 mg, 20 mg, 40 mg and 80 mg, of Pfizer Inc., and indicated to lower cholesterol in blood for adults and children over 10 years of age.Atorvastatin is also prescribed to lower the risk of heart attack and stroke in patients with cardiovascular diseases, diabetes and other risk factors such as eye problems, kidney diseases or high blood pressure.Atorvastatin calcium tablets USP (RLD: Lipitor) had annual sales of approximately US$ 559 million in the US (IQVIA MAT July 2020).
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!